Nov 7, 2025 · Recently, with the emergence and development of detection technologies, various sepsis-related biomarkers have emerged. Biomarkers could be considered as indicators of either infection …

Aug 19, 2024 · This review summarizes the latest advancements in sepsis biomarker research, spotlighting the progress and clinical implications. It emphasizes the significance of multi-biomarker …

Numerous biomarkers have been studied for their potential value in the diagnosis of sepsis, and more than 250 different biomarkers have been proposed. However, many of these biomarkers are more …

biomarkers for the prediction of diagnosis and the severity of sepsis (4,5). MCP-1 is a soluble chemokine that is secreted by monocytes, endothelial cells, fibroblasts and other cells under pro-inflammatory …

In this review we discuss these specific applications for the following existing and emerging biomarkers: procalcitonin, presepsin, pentraxin-3, and pancreatic stone proteins in sepsis. Finally, we discuss …

Oct 10, 2025 · Emerging biomarkers, including Presepsin (PSEP), Pancreatic Stone Protein (PSP), and Myxovirus Resistance Protein A (MxA), demonstrate higher sensitivity and specificity, providing more …

Biomarkers have emerged as valuable tools for early detection, risk stratification, and monitoring treatment response in sepsis patients. This review explores the most clinically relevant sepsis …

Dec 4, 2025 · In addition to evaluating the effectiveness of integrated multi-biomarker panels for early identification, risk stratification, and treatment monitoring in critically ill patients, this systematic …

23 hours ago · What role do biomarkers play in improving treatment decision-making for sepsis patients? How is artificial intelligence influencing predictive diagnosis and clinical workflows? What …

In recent years, biochemical markers have emerged as valuable tools in identifying sepsis at an early stage and predicting disease severity. Among these markers, C-reactive protein (CRP) and …